Key figures
- Revenue: $40.1 million (prior period: $31.1 million; up 29.1%)
- Result: net profit after tax of $12.9 million (prior period: net profit after tax of $6.8 million; up 89.0%)
- Underlying EBITDAF: $6.6 million (prior period: $4.2 million; up 57.8%)
- EBITDAF: $6.4 million (prior period: $4.6 million; up 38.4%)
- Profit before income tax expense: $13.9 million (prior period: $6.7 million; up 108.7%)
- Basic earnings per share: 24.52 cents per share (prior period: 13.95 cents per share)
- Dividend: none declared for the period
FY2026 results
Total revenue for the period was $40.1 million. Underlying EBITDAF was $6.6 million, and EBITDAF was $6.4 million. Profit before income tax expense was $13.9 million, and basic earnings per share was 24.52 cents per share.
Compared with the prior period
Revenue was up 29.1% on $31.1 million in the prior period, and Underlying EBITDAF was up 57.8% against $4.2 million. Compared with a net profit after tax of $6.8 million in the prior period, the statutory result moved up 89.0%.
In the company's words
For FY27, Promisia expects underlying EBITDAF to increase to at least $8.0 million, representing more than 20% year-on-year growth.
---
Source: Promisia Healthcare Limited, "PHL delivers strong FY26 result and sets dividend policy" (27 May 2026), https://www.nzx.com/announcements/473459.
Updated 24 October 2026: rewritten so that every figure is taken directly from the company's announcement. Earlier versions of these automated articles contained errors. This article was generated from the company's NZX results announcement by NZXplorer's automated reporting system. Every figure is taken from that announcement. It is provided for information only and is not financial advice.